VLCC to market CMFRI’s anti-obesity product The New Indian Express dated 29th May 2017
Abstract
The Central Marine Fisheries Research Institute (CMFRI) has given VLCC the exclusive licence to use its recently-developed anti-obesity nutraceutical product CadalminTM Antihypercholesterolemic extract (CadalminTM ACe) for commercial production and marketingSimilar works
Full text
Last time updated on 18/06/2017
This paper was published in CMFRI Digital Repository.
Having an issue?
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.